ArticleOncology letters2023

SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma.

Junqing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.